News Focus
News Focus
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: Robert C Jonson post# 75945

Thursday, 03/01/2012 12:39:09 PM

Thursday, March 01, 2012 12:39:09 PM

Post# of 347009
PPHMoownsme et al...Dear asmarterwookie,(lol)

Thanks for your interest in Peregrine and the upcoming AACR Annual Meeting.
The antibody used in Dr Thorpe's abstract below is a mouse version of one of Peregrine's PS-targeting antibodies.

Best Regards,
Jay

Jay Carlson | Manager, Investor Relations

Peregrine Pharmaceuticals, Inc.
14282 Franklin Avenue - Tustin, Ca - 92780
Tel: +1.714.508.6042 | Corporate: +1.714.508.6000 | Fax: +1.714.838.9433
jcarlson@peregrineinc.com<mailto:jcarlson@peregrineinc.com> | http://www.peregrineinc.com<http://www.peregrineinc.com/>;




Is Peregrine a part of this or is Dr. Thorpe collaborating outside of Peregrine?



Presentation Title: Cure of castration-resistant prostate cancer in TRAMP mice by reactivating tumor immunity with a phosphatidylserine-targeting antibody
Presentation Time: Tuesday, Apr 03, 2012, 1:00 PM - 5:00 PM
Location: McCormick Place West (Hall F), Poster Section 19
Poster Board Number: 12
Author Block: Yi Yin, Xianming Huang, Gustavo Barbero, Dan Ye, Philip E. Thorpe. UT Southwestern Medical Ctr., Dallas, TX


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y